We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Dedicated to our clients' success
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
11 March 2019
Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, has entered into a debt financing agreement with Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) for up to USD 100 million. Urovant plans to use the proceeds to fund ongoing development of its lead compound vibegron, for business development opportunities, and for general corporate purposes.
VISCHER advised Urovant Sciences as Swiss counsel. The VISCHER Team included Dr. Adrian Dörig (Partner, Banking & Finance), Ruben Masar (Senior Associate, Corporate), Julian Merz (Associate, Banking & Finance) and Christoph Niederer (Partner, Tax).
Categories: Banking & Finance, Startup Desk, Tax, Deals & Cases
Attorney at Law
Attorney at Law / Honorary Consul of the Slovak Republic
Attorney at Law, Swiss Certified Tax Expert
On 28 December 2023, Danstar Ferment AG, a Swiss subsidiary of Canadian multi-national, Lallemand...
We are pleased to announce that several of our lawyers have been recognized as national leaders in...
Date: 7 June 2023 Organizer: VISCHER AG and Swiss-Chinese Chamber of Commerce (SCCC) Location:...